Director, GLP-1 and Cardiometabolic Health Program Manager Omada Health is on a mission to bend the curve of chronic disease
Kokkorakis M, Chakhtoura M, Rhayem C et al (2025) Emerging pharmacotherapies for obesity: a systematic review
The study results also showed that dysesthesia and urinary tract infections were reported in around one in ten patients on the highest doses of retatrutide but they were generally mild-to-moderate symptoms and the majority were resolved during treatment, while most participants continued taking retatrutide
Our weight loss program is built around clear protocols, ongoing medical oversight, and personalized guidance designed to support sustainable progress over time
How to use: Adults: Take 1 capsule daily with food, or follow the product label or healthcare professional directions
Immunofluorescence test combined with Mitotracker staining Adipocyte-differentiating transfected/non-transfected 3T3-L1 cells were treated with Met combined with L-car, together with or without SFA